VG
venBio Global Strategic Fund II L.P.
Other
Browse the complete record of transactions filed by venBio Global Strategic Fund II L.P.. Director active across 1 company, notably Checkmate Pharmaceuticals, Inc.. In total, 7 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €7m. Activity tracked since 19 April 2022. The latest transaction was filed on 13 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
35,850 shares@ US$10.44535.2% of flowCommon StockSEC:0001567619-22-011111:0
18,676 shares@ US$10.38072.6% of flowCommon StockSEC:0001567619-22-010353:0
20,743 shares@ US$10.372.9% of flowCommon StockSEC:0001567619-22-009850:0
153,700 shares@ US$10.383721.8% of flowCommon StockSEC:0001567619-22-009528:0
47,396 shares@ US$10.38026.7% of flowCommon StockSEC:0001567619-22-009203:0
37,430 shares@ US$10.38835.2% of flowCommon StockSEC:0001567619-22-008985:0
399,923 shares@ US$10.415155.5% of flowCommon StockSEC:0001567619-22-008823:0
About venBio Global Strategic Fund II L.P.
venBio Global Strategic Fund II L.P. is a director and insider at Checkmate Pharmaceuticals, Inc.